Clinical trial
SVT-15652 Otic Solution for the Treatment of Otomycosis.
NCT03686397 · Salvat, Industry · Completed
Key facts
| NCT number | NCT03686397 |
|---|---|
| Title | SVT-15652 Otic Solution for the Treatment of Otomycosis. |
| Official title | A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis). |
| Lead sponsor | Salvat, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Otomycosis |
| Intervention type | Drug |
| Interventions | SVT-15652, Placebo |
| Enrollment | 194 |
| Start date | Jun 9, 2020 |
| Primary completion | Oct 19, 2021 |
| Completion | Oct 19, 2021 |
| First posted | Sep 26, 2018 |
| Last update posted | Dec 15, 2022 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: